Option chain shows key data for WuXi Biologics (Cayman)'s stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for WuXi Biologics (Cayman).

WuXi Biologics (Cayman) (OTC:WXXWY) Stock, Option Chain

WuXi Biologics is one of the largest global biologic global contract development and manufacturing organizations. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 18.7 billion. North America represented 57.3% of total revenue in 2024. The firm has a "follow and win the molecule" strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual sourcing strategy by providing drug products and drug substance manufacturing.

Trump Orders Crackdown On Chinese Investments In Key Sectors Including Technology Citing 'National Security' Concern

News

Politics

Markets

PHBBF

WUXAY

WXXWY

President Donald Trump has issued a stringent warning to pharmaceutical companies, advising them to repatriate their manufacturing to the US or face the possibility of tariffs.

Trump Reportedly Warns Big Pharma: Move Manufacturing To US Or Face Tariffs

US-China (Tatiana Popova and rawf8 by Shuttterstock)

Biotech

Health Care

General

Amidst regulatory challenges, WuXi AppTec faces backlash from industry giants. Biotechnology Innovation Organization cuts ties, citing national security concerns. Shares plummet as U.S. bills target Chinese biotech firms, despite denials and partnerships with global pharmaceutical players.

Congressional Scrutiny Intensifies On Chinese Biotech Firms:  WuXi AppTec Faces Biotech Exodus

Asia

Penny Stocks

AAGIY

BABA

CICHY

HNSPF

MPNGY

PNGAY

SBMFF

TCEHY

TSLA

XPEV

NIKE

Hong Kong stocks rallied Friday as the week closed out higher for consumer stocks and EV makers which investors hope will be the beneficiary of a forthcoming government stimulus.  

The Hang Seng Index ended the day 2.1% higher at 17,398.73 while China’s CSI 300 Index rose 1.4% to 3,562.39.

Strong Consumer Turnout Drives Hong Kong Stocks Higher Friday As China&#39;s Former Premier Li Keqiang Dies At 68

WUXI BIOLOGICS UNSP/ADR by Wuxi Biologics (Cayman) Inc

WuXi Biologics (Cayman) Inc

Press Releases

WuXi Biologics Launches EffiX™ Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA Production

Commodities

WuXi Biologics Included in S&P Global Sustainability Yearbook 2025

WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year

WuXi Biologics Receives CDMO Leadership Awards for Eighth Consecutive Year

Earnings

WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025

WuXi Biologics Wins Five Asia-Pacific Biopharma Excellence Awards

WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site

WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year

Driving Impact Through Responsibility: WuXi Biologics Releases 2024 Sustainability Report

WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA

WuXi Biologics (Cayman)

Comments

WuXi Biologics (Cayman)

WuXi Biologics (Cayman) (WXXWY) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell